Incidence and risk factors for recurrent sexually transmitted infections among MSM on HIV pre-exposure prophylaxis-Reference-Cited by-同舟云学术

Incidence and risk factors for recurrent sexually transmitted infections among MSM on HIV pre-exposure prophylaxis

Published:2022-02-09 Issue:8 Volume:36 Page:1129-1134
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:

Author:

Zeggagh Jérémy,Bauer Rebecca,Delaugerre Constance,Carette Diane,Fressard Lisa,Charreau Isabelle,Chidiac Christian,Pialoux Gilles,Tremblay Cécile,Cua Eric,Robineau Olivier,Raffi François,Capitant Catherine,Spire Bruno,Meyer Laurence,Molina Jean Michel,

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference24 articles.

1. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men;Grant;N Engl J Med,2010

2. Preexposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial;McCormack;Lancet,2016

3. On-demand preexposure prophylaxis in men at high risk for HIV-1 infection;Molina;N Engl J Med,2015

4. Efficacy, safety, and effect on sexual behaviour of on-demand preexposure prophylaxis for HIV in men who have sex with men: an observational cohort study;Molina;Lancet HIV,2017

5. Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2020 recommendations of the International Antiviral Society-USA Panel;Saag;JAMA,2020

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bacterial sexually transmitted infections among men who have sex with men and transgender women using oral pre-exposure prophylaxis in Latin America (ImPrEP): a secondary analysis of a prospective, open-label, multicentre study;The Lancet HIV;2024-09

2. CDC Clinical Guidelines on the Use of Doxycycline Postexposure Prophylaxis for Bacterial Sexually Transmitted Infection Prevention, United States, 2024;MMWR. Recommendations and Reports;2024-06-06

3. Doxycycline prophylaxis and meningococcal group B vaccine to prevent bacterial sexually transmitted infections in France (ANRS 174 DOXYVAC): a multicentre, open-label, randomised trial with a 2 × 2 factorial design;The Lancet Infectious Diseases;2024-05

4. Sexual behaviour and STIs among MSM living with HIV in the PrEP era: the French ANRS PRIMO cohort study;Journal of the International AIDS Society;2024-03

5. Are reinfections undermining HCV elimination efforts?;The Lancet HIV;2024-02